<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Downs Rindom | Activity</title>
	<link>https://recash.wpsoul.net/members/carrotate09/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/carrotate09/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Downs Rindom.</description>
	<lastBuildDate>Wed, 20 May 2026 01:55:22 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">fb5c8dcf8c855f8b6e7d869798279101</guid>
				<title>Downs Rindom posted an update: While the experience with PCSK9i in patients with coronary [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/49047/</link>
				<pubDate>Wed, 11 Dec 2024 10:38:21 +0000</pubDate>

									<content:encoded><![CDATA[<p>While the experience with PCSK9i in patients with coronary artery disease has been wide, and coronary plaque regression has been documented, little is known regarding the role of these drugs on carotid plaque regression. The CARotid plaqUe StabilizatiOn and regression with evolocumab (CARUSO) study is a randomized, single-center,&hellip;<span class="activity-read-more" id="activity-read-more-49047"><a href="https://recash.wpsoul.net/activity/p/49047/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0ae580854a8baf0d0877b06f5033046f</guid>
				<title>Downs Rindom became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/48905/</link>
				<pubDate>Wed, 11 Dec 2024 10:27:33 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>